Login
Register
Your login | |
Your password | |
Confirm your password | |
Your email | |
I agree to receive the R3i newsletter | |
Current position | |
1994 - | Professor of Medicine, Chief, Division of Nephrology, Dept of Medicine and Scientific director, Clinical Trial Unit, University Hospital of Würzburg Julius-Maximilians-University, Würzburg, Germany |
Past position | |
1991 | Assistant Professor and faculty member |
1992 | Research sebatical at the NIH, NHLBI, Molecular Disease Branch (B. Brewer), USA |
Scientific training | |
1983 - 1989 | Residency and internship at the Universities of Zurich, Switzerland and Freiburg, Germany |
1990 | Habilitation (equivalent to PhD) |
Professional Associations | |
Steering committee member and central Europe coordinator of SHARP (study of heart and renal protection). | |
Publicatins (selection) | |
R3i related paper: Wanner C, Krane V, März W, Olschewski M, Mann JFE, Ruf G, Ritz E for the German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. New Engl J Med 2005;353:238-248 |
|
Best cited paper (710 citations): Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-658 |
|
Research | |
Scientific areas of interest are : (1) the role of lipids in the progression of renal and vascular disease (glomerulosclerosis and atherosclerosis in kidney failure patients) (2) elucidation of the inflammatory response syndrome in diabetic nephropathy, chronic kidney disease and kidney failure. 1998-2005 PI of the 4D study, a statin outcome trial in diabetic patients on dialysis |
|